2025 - Cancer Currents Blog
-
As diagnoses of colorectal, breast, and other cancers continue to climb in people under age 50, researchers are trying to understand what’s behind this phenomenon. Is it environmental exposures, genetics, lifestyle? The culprits, they say, remain unclear.
-
Scientists have developed a test for use during brain cancer surgery that rapidly measures the levels of certain genetic mutations in patients’ tumor samples. The test uses droplet digital polymerase chain reaction technology and produces results within 15 minutes.
-
A device that measures the “stickiness” of cancer cells in tumor samples may help predict the likelihood of a patient’s cancer metastasizing. Researchers believe the device could eventually help doctors make more informed treatment choices.
-
FDA has approved the combination of the immunotherapy drugs ipilimumab (Yervoy) and nivolumab (Opdivo) for the initial treatment of people with advanced colorectal cancer whose tumors are classified as MSI-H or dMMR.